| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/08/2009 | US20090011466 Concatameric immunoadhesion molecule |
| 01/08/2009 | US20090011465 Covalently attached to a nonpeptide moiety; nucleic acids encoding the polypeptides; reducing the number of copies of a virus in infected cells |
| 01/08/2009 | US20090011464 Humanized immunoglubulin reactive with alph4beta7 integrin |
| 01/08/2009 | US20090011461 Human Spasmolytic Polypeptide in Glycosylated Form |
| 01/08/2009 | US20090011434 Methods And Compositions For Diagnosing Breast Cancer |
| 01/08/2009 | US20090011036 Drug containing hollow protein nanoparticles of particle-forming protein, fused with disease-treating target-cell-substance |
| 01/08/2009 | US20090011032 Methods for improved cryo-chemotherapy tissue ablation |
| 01/08/2009 | US20090011028 Self-precipitating pharmaceutical formulations for the moified release of an active principle |
| 01/08/2009 | US20090011021 Engineered Extracellular Matrices |
| 01/08/2009 | US20090011008 Nanoparticles for protein drug delivery |
| 01/08/2009 | US20090011000 Inhibitors of Infection |
| 01/08/2009 | US20090010996 Human antibiotic proteins |
| 01/08/2009 | US20090010988 Composition of bone formation with phsrn-rgd containing oligopeptide |
| 01/08/2009 | US20090010987 Methods and Devices for Reducing Tissue Damage After Ischemic Injury |
| 01/08/2009 | US20090010985 Article with Lubricated Surface and Method |
| 01/08/2009 | US20090010967 Clostridial toxin derivatives and methods for treating pain |
| 01/08/2009 | US20090010953 Peptides of a melanoma antigen and their use in diagnostic, prophylactic, and therapeutic methods |
| 01/08/2009 | US20090010952 Pharmaceutical compound for effecting localized, non-systemic and systemic, immunogenic treatment of cancer using crt or erp57 translocation |
| 01/08/2009 | US20090010951 Epitope/Peptide Recognized By Hla-A2402-Restricted Ep/Cam-Specific Ctl And Use Of The Same |
| 01/08/2009 | US20090010946 Novel Stromal Cell-Derived Factor-1 Polypeptides, Polynucleotides, Modulators Thereof and Methods of Use |
| 01/08/2009 | US20090010945 conjugating drug to antibody by reducing antibody with reducing agent, treating antibody with reoxidizing agent to reform interchain disulfide bond of antibody to form partially reoxidized antibody such that two cysteine thiols remain, conjugating drug to interchain thiol of antibody via maleimide group |
| 01/08/2009 | US20090010943 Peptides associated with HLA-DR MHC class II molecule and involved in Rheumatoid arthritis |
| 01/08/2009 | US20090010941 Methods for treating HIV |
| 01/08/2009 | US20090010940 Parathyroid Hormone Analogues and Methods of Use |
| 01/08/2009 | US20090010937 Membrane Attack Complexes Associated with Circulating Immune Complexes |
| 01/08/2009 | US20090010936 Novel Stra6 Polypeptides |
| 01/08/2009 | US20090010935 Compositions and Methods of Treating Tumors |
| 01/08/2009 | US20090010933 inhibiting vascularization or angiogenesis using chimeric proteins, immunoglobulin-like domains of tyrosine kinase receptors |
| 01/08/2009 | US20090010927 Mapkap kinase-2 as a specific target for blocking proliferation of P53-defective cells |
| 01/08/2009 | US20090010925 Antibody variants |
| 01/08/2009 | US20090010922 Compositions and methods for binding sphingosine-1-phosphate |
| 01/08/2009 | US20090010920 Fc Variants Having Decreased Affinity for FcyRIIb |
| 01/08/2009 | US20090010919 Diagnostics and Therapeutics for Diseases Associated With Fibroblast Activation Protein (Fap) |
| 01/08/2009 | US20090010918 Methods for treatment using collagenase |
| 01/08/2009 | US20090010917 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor; apoptosis-inducing factor |
| 01/08/2009 | US20090010916 C-1 Inhibitor prevents non-specific plasminogen activation by a prourokinase mutant without impeding fibrin-specific fibrinolysis |
| 01/08/2009 | US20090010915 Methods for Conducting Metabolic Analyses |
| 01/08/2009 | US20090010914 Use of Oligouronates for Treating Mucus Hyperviscosity |
| 01/08/2009 | US20090010913 Natural liniment for treatment of skin cancers |
| 01/08/2009 | US20090010912 Use of Alkaline Phosphatase for the Detoxification of Lps Present at Mucosal Barriers |
| 01/08/2009 | US20090010911 Methods and compositions for affecting cyclophilin a regulation of kinases in modulating cellular activities |
| 01/08/2009 | US20090010910 Compositions and methods for dermatological wound healing |
| 01/08/2009 | US20090010909 Novel GPCR and methods of use of the same |
| 01/08/2009 | US20090010907 Dnazymes for Inhibition of Japanese Encephalitis Virus Replication |
| 01/08/2009 | US20090010906 Peroral dosage forms to achieve a sustained-release effect after medicament dosage with a meal |
| 01/08/2009 | US20090010903 using ferulate esterase producing bacterial strains or functional mutants thereof as a silage inoculant for improving fiber digestibility; treating pre-ensiled plant material to enhance the digestibility of the resulting silage |
| 01/08/2009 | US20090010894 Methods and systems for identifying compounds that modulate alpha-synuclein aggregation |
| 01/08/2009 | US20090010887 Method and composition for enhancing anti-angiogenic therapy |
| 01/08/2009 | US20090010886 Method for the Treatment of Myeloproliferative Diseases Using(+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2- Methylsulfonylethyl]-4- Acetylaminoisoindoline-1,3- Dione |
| 01/08/2009 | US20090010885 Methods for Detecting and Treating Autoimmune Disorders |
| 01/08/2009 | US20090010884 Pharmaceutical compositions and methods of preventing, treating, or inhibiting inflammatory diseases, disorders, or conditions of the skin, and diseases, disorders, or conditions associated with collagen depletion |
| 01/08/2009 | US20090010883 Using endothelial growth factor specific immunoglobulin as therapeutic tool in treatment of metastatic gastric or stomach cancer |
| 01/08/2009 | US20090010882 Polymorphs of sodium 4-4[(4-chloro-2-hydroxybenzoyl) amino] butanoate |
| 01/08/2009 | US20090010881 Using endothelial growth factor specific immunoglobulin as therapeutic tool in treatment of bladder cancer |
| 01/08/2009 | US20090010880 2-Amino-2,7-dideoxy-alpha-D-glycero-D-gluco-heptopyranosyl Inhibitors of Positive Sense Single-Stranded RNA Envelope Viruses |
| 01/08/2009 | US20090010879 Receptor Based Antagonists and Methods of Making and Using |
| 01/08/2009 | US20090010878 Pulsatile dosing of gossypol for treatment of disease |
| 01/08/2009 | US20090010877 Methods for treatment prostate cancer using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 01/08/2009 | US20090010876 Visfatin and uses thereof |
| 01/08/2009 | US20090010875 IL-7 Fusion Proteins |
| 01/08/2009 | US20090010874 Modified il-4 mutein receptor antagonists |
| 01/08/2009 | US20090010873 Methods of Cell Therapy, Neurogenesis and Oligodendrogenesis |
| 01/08/2009 | US20090010872 Chimeric soluble hyper il-11 and use thereof |
| 01/08/2009 | US20090010869 Compositions for Topical Enzymatic Debridement |
| 01/08/2009 | US20090010854 Pulmonary insulin crystals |
| 01/08/2009 | US20090010848 Recombinant Peptides Derived from the Mc3 Anti-BA46 Antibody, Methods of Use Thereof, and Methods of Humanizing Antibody Peptides |
| 01/08/2009 | US20090010847 Connective Tissue Growth Factor-4 |
| 01/08/2009 | US20090010842 Methods for the early diagnosis of ovarian cancer |
| 01/08/2009 | US20090010839 Avidin dimers effective in increasing the concentration of radioactive biotin in pretargeted radioimmunotherapy |
| 01/08/2009 | DE102007031417A1 Hyaluronate lyase with a histidine tag e.g. useful in pharmaceutical formulations and medical products |
| 01/08/2009 | DE102005054700B4 Neue duale Peptidase-Inhibitoren als Prodrugs zur Therapie von entzündlichen und anderen Erkrankungen New dual peptidase inhibitors as prodrugs for the treatment of inflammatory and other diseases |
| 01/08/2009 | CA2722015A1 Compositions and methods of use for alpha-1 antitrypsin having no significant serine protease inhibitor activity |
| 01/08/2009 | CA2692603A1 Peptides facilitating retrograde transport and their uses |
| 01/08/2009 | CA2692509A1 Compounds and methods for the treatment of renal disease |
| 01/08/2009 | CA2692495A1 Proteinases destroy cancer tumor's solid structure and kill cancer cells locally |
| 01/08/2009 | CA2692412A1 Treatment for anxiety |
| 01/08/2009 | CA2692320A1 Methods of treating bone disorders with modulators of axl |
| 01/08/2009 | CA2692231A1 Liquid protein formulations comprising gdf-5 for use at elevated temperatures |
| 01/08/2009 | CA2692190A1 Novel compounds, use thereof in cosmetic and cosmeceutic applications, and compositions comprising same |
| 01/08/2009 | CA2691736A1 Combination of 6-(3-chloro-2-fluorobenzyl)-1-[(2s)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid and lopinavir for the treatment of a viral infection in a human |
| 01/08/2009 | CA2690370A1 Modified globin proteins with altered electron transport pathway |
| 01/08/2009 | CA2688313A1 Composition for mucosal administration containing agent for enhancing mucosal absorption of peptide drug, and administration method thereof |
| 01/07/2009 | EP2012124A2 Method for immuno-detection of epitopes on molecules and for detection of interactions of molecules via fluorescent dyes |
| 01/07/2009 | EP2011877A2 Conjugates for the modulation of immune responses |
| 01/07/2009 | EP2011875A1 Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods |
| 01/07/2009 | EP2011874A1 Recombinant gelatin in vaccines |
| 01/07/2009 | EP2011801A1 Immunoconjugates having high binding affinity |
| 01/07/2009 | EP2011800A2 Inhibitors of caspase |
| 01/07/2009 | EP2011514A1 A preventive or therapeutic agent for sensitized T cell-mediated diseases comprising IL-6 antagonist as an active ingredient |
| 01/07/2009 | EP2011512A1 An anti HSP90 antibody |
| 01/07/2009 | EP2011510A2 Pharmaceutical compositions comprising immunologically active herpes simplex virus (HSV) protein fragments |
| 01/07/2009 | EP2011509A2 Pharmaceutical composition containing the nmb0606 protein |
| 01/07/2009 | EP2011508A1 Use of trap protein as active ingredient for manufacturing a medicament for the treatment of staphylococcus aureus infection |
| 01/07/2009 | EP2011507A2 Pharmaceutical composition of nateglinide and another antidiabetic agent |
| 01/07/2009 | EP2010673A2 Means and methods for diagnosing and treating cancer based on the frmd3 gene |
| 01/07/2009 | EP2010564A2 The homeobox transcription factor bsx and uses thereof for treating diseases, in particular obesity |
| 01/07/2009 | EP2010562A1 Novel polypeptides inducing dendritic cell migration, as well as medicines and pharmaceutical compositions containing same |
| 01/07/2009 | EP2010561A1 Antimicrobial peptides |
| 01/07/2009 | EP2010556A2 Homogeneous erythropoietin and other peptides and proteins, methods and intermediates for their preparation |
| 01/07/2009 | EP2010226A2 Transcobalamin receptor polypeptides, nucleic acids, and modulators thereof, and related methods of use in modulating cell growth and treating cancer and cobalamin deficiency |